Early-childhood body mass index and its association with the COVID 19 pandemic, containment measures and islet autoimmunity in children with increased risk for type 1 diabetes
S. Hummel, A.G. Ziegler et al. Diabetologia 2024
https://pubmed.ncbi.nlm.nih.gov/38214711/

Infection episodes and islet autoantibodies in children at increased risk for type 1 diabetes before and during the COVID-19 pandemic
I. Zeller, A.G. Ziegler et al. Infection 2024
https://pubmed.ncbi.nlm.nih.gov/38874748/

Clinical care advice for monitoring of islet autoantibody positive individuals with presymptomatic type 1 diabetes
E. Hendriks, L. Marcovecchio et al. Diabetes Metab Res Rev. 2024
https://pubmed.ncbi.nlm.nih.gov/38375753/

Vitamin D insufficiency in infants with increased risk of developing type 1 diabetes: a secondary analysis of the POInT Study
A. Jacobs, M. Warnants, V. Vollmuth et al. BMJ Paediatr Open. 2024
https://pubmed.ncbi.nlm.nih.gov/38216311/

SARS-CoV-2 infection and development of islet autoimmunity in early childhood
E. Bonifacio, M. Lugar, A. Eugster et al. Jama. 2023
https://jamanetwork.com/journals/jama/fullarticle/2809621

The emotional well-being of parents with children at genetic risk for type 1 diabetes before and during participation in the POInT-study
J. Houben, M. Janssens, C. Winkler et al. Pediatr Diabetes 2022
https://pubmed.ncbi.nlm.nih.gov/36323590/

Elevations in blood glucose before and after the appearance of islet autoantibodies in children
K. Warncke, A. Weiss, P. Achenbach et al. J Clin Invest. 2022
https://pubmed.ncbi.nlm.nih.gov/36250461/

Maternal type 1 diabetes and alterations in blood DNA methylation of their offspring
S. Hummel, R. Ott, A.G. Ziegler
(submitted)

Genetics of circulating proteins in newborn babies identifies drivers of type 1 diabetes risk and therapeutic targets
Proteomics Project done in Dried Blood Spots using samples POInT participants
(in revision)